Substance abuse vulnerability and D2 receptor genes.
Dopamine systems are key to the actions of several substances. Inter-individual differences in genes encoding proteins involved in dopaminergic neurotransmission could plausibly explain some of the genetic bases for inter-individual differences in vulnerability to substance abuse. The restriction fragment length polymorphism (RFLP) markers TaqIA1 and B1 at the dopamine D2 receptor (DRD2) gene locus in Caucasians are associated with substance abuse behaviors. In most, but not all, studies of alcoholics and polysubstance abusers, these TaqIA1 and B1 gene markers are present more often in substance abusers than in control individuals. No study has identified substance abusers or controls by sampling randomly from the general population; allelic association findings could thus conceivably be confounded by RFLP differences based on ethnicity or other factors. However, meta-analyses of the data from controlled studies available to date are consistent with the proposal that DRD2 gene variants contribute to inter-individual differences in vulnerability to alcoholism and polysubstance abuse.
Uhl
G
G
Laboratory of Molecular Neurobiology, National Institute on Drug Abuse, Baltimore, MD 21224.
Blum
K
K
Noble
E
E
Smith
S
S
D000818:Animals; D006801:Humans; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D019966:Substance-Related Disorders / Q000235:genetics*
D017448:Receptors, Dopamine D2